PASER
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PASER, covering 2008-10-15 to 2017-09-21. Get the full timeline:
Most recent: Clinical Trial Update: High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children [Phase 2]